- Research article
- Open Access
Administration of mulberry leaves maintains pancreatic β-cell mass in obese/type 2 diabetes mellitus mouse model
BMC Complementary Medicine and Therapies volume 20, Article number: 136 (2020)
Type 2 diabetes mellitus is characterized by insulin resistance and pancreatic β-cell dysfunction. A decrease in β-cell mass, which occurs during the progression of Type 2 diabetes mellitus, contributes to impaired insulin secretion. Mulberry leaves contain various nutritional components that exert anti-diabetic and anti-atherogenic effects. The present study analyzed the effects of mulberry leaf intake on pancreatic β-cells to clarify the mechanisms underlying its anti-diabetic function.
Mulberry leaves (Morus alba L.) were dried at 180 °C for 8 s in a hot-air mill and fed to obesity/Type 2 diabetes mellitus db/db mouse models at 5% (w/w) as part of a normal diet from 7 to 10, 15, or 20 weeks of age. An intraperitoneal glucose tolerance test was then performed on the mice. To evaluate the β-cell mass, the pancreas was subjected to immunohistological analysis with an anti-insulin antibody. A TUNEL assay and immunohistological analysis with a proliferation marker was also performed. Expression levels of endoplasmic reticulum stress-responsible genes and proliferation markers were assessed by quantitative RT-PCR.
Intake of mulberry leaves maintained the β-cell function of db/db mice. Moreover, oral administration of mulberry leaves significantly decreased cell death by reducing endoplasmic reticulum stress in the pancreas. Mulberry leaves significantly increased proliferation of β-cells and the expression of pancreatic duodenal homeobox1 mRNA in the pancreas.
Considered together, these results indicate that dietary mulberry leaf administration can maintain insulin levels and pancreatic β-cell mass, at least in part, by suppressing endoplasmic reticulum stress in Type 2 diabetes mellitus mouse models.
Obesity is considered a critical issue worldwide. It is known that obesity may lead to certain metabolic disorders such as cardiovascular disease and diabetes mellitus . The number of diabetic patients is estimated to be over 400 million, globally . Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and the dysfunction of insulin producing β-cells in the islets of Langerhans of the pancreas [3, 4]. Many studies have indicated that insulin resistance precedes hyperglycemia, which eventually leads to T2DM [5,6,7]. During the progression of insulin resistance, decreased glucose-intake in adipose tissues and muscles, compounded by enhanced gluconeogenesis and glycogenolysis in the liver, may cause chronic high blood glucose levels leading to increased insulin demand. Weir et al. classifies progression in two stages. Stage 1 is the compensation stage, which occurs during diabetes progression, whereby β-cell adaptation increases in the β-cell area in the pancreas in order to upregulate insulin secretion in response to the increased demand for insulin. Subsequently, stage 2 is the decompensation stage, when the β-cell area decreases due to activation of cell death by higher endoplasmic reticulum (ER) stress and oxidative stress conditions [8, 9].
Recent studies have indicated that unfolded proteins are important factors that cause insulin resistance by stimulating ER stress. Unfolded proteins are present in white adipose tissue, pancreas, liver, and skeletal muscles of insulin resistant rodents . In the ER lumen, a HSP70 molecular chaperone, immunoglobulin heavy-chain binding protein (BiP), also called glucose related protein 78 (GRP78), plays a role in the folding of unfolded proteins. Its activity is regulated by binding with an ER stress sensor protein, inositol requiring enzyme 1 (IRE1), PKR like endoplasmic reticulum kinase (PERK) or activating transcription factor 6 (ATF6) . During unfolded protein response (UPR), BiP dissociates from IRE1, PERK, or ATF6, and binds to unfolded proteins , thereby activating the ER stress sensor protein to promote the translocation of factors such as activating transcription factor 4 (ATF4) and x-box binding protein 1 (XBP1). These factors induce the expression of ER chaperon proteins and pro-apoptosis proteins, including the C/EBP homologous protein (CHOP) . Excess ER stress leads to the accumulation of unfolded proteins within the ER, eventually causing cell death. Pancreatic β-cells, in particular, produce and secrete insulin to regulate glucose concentration in plasma following a meal or hormone release, thereby inducing the reuptake of glucose by cells. Increased secretion of insulin under hyperglycemic conditions may overwhelm the capacity of the ER, causing ER dysfunction. Many studies have revealed that in vivo deletion of Chop or Atf4 knockout in Akita spontaneous diabetes mouse models, not only protected β-cells from cell apoptosis, but also improved protein folding in the ER . Other reports indicated that Xbp1 deficiency caused hyperglycemia and glucose intolerance in mice . The deficiency of p85α, a regulatory subunit of phosphatidylinositol-3-kinase (PI3K), in Akita mice reduced ER stress and the protein expression level of Xbp1, a transcription factor involved in UPR in β-cells, thus delaying activation of the apoptotic pathway .
Intake of mulberry leaves (ML) (Morus alba L; Moraceae), commonly used as a diet for silkworms (Bombyx mori L.), exerts beneficial anti-hyperglycemic effects in humans , anti-atherogenic effects in mice , as well as antioxidant effects. ML is used to treat diabetes in Chinese medicine . Studies conducted by us previously indicated that oral administration of ML ameliorated dysregulation of adipocytokine in the white adipose tissue (WAT) of db/db mouse obesity and T2DM models . ML contains 1-deoxynojirimycin (DNJ), a glucose analog which suppresses postprandial blood glucose levels by inhibiting α-glucosidase. ML also contains a rich antioxidant which may reduce reactive oxygen species (ROS) . We previously reported that administration of ML ameliorated abnormal glucose tolerance and suppressed the expression of NADPH oxidase, a ROS generating enzyme, in the WAT and liver of db/db mice, resulting in the reduction of oxidative stress . Some studies have also described the effects of antioxidants contained in ML. Youl et al., reported that quercetin enhanced insulin secretion and reduced oxidative damage in rat pancreatic islets treated with H2O2 . Similarly, administration of isoquercetin for 5 weeks lowered blood glucose levels in KK-Ay mouse non-insulin-dependent diabetes models . These flavonoids are known to be components of ML.
We found that oral administration of ML to db/db mouse obesity/T2DM models improved glucose tolerance, indicating an effect of ML on insulin secretion in the pancreas. However, the effects of ML intake on β-cells are yet to be revealed. Thus, the objective of the present study was to investigate the effects of oral ML administration on pancreatic function in db/db mice.
This study was performed with the approval of the Institutional Animal Care and Use Committees (IACUC), ethics committee of Kyoto University (approval No. MedKyo 19,301). All sections of this report are based on the ARRIVE Guidelines for reporting animal research . The mice were deeply anesthetized with 40 mg/kg of pentobarbital sodium (Kyoritsu Seiyaku, Tokyo, Japan); according to terminal procedures under anesthesia, blood was withdrawn and tissues were collected. All efforts were made to minimize suffering.
The three races of Mulberry tree (Morus alba L.), “Hayate-sakari,” “Ichinose,” and “Minamisakari” had been stocked in the experimental farm of Kyoto Institute of Technology. These were transplanted to Kyotango Furusato Farm (Kyoto, Japan) by planting branches, and cultured using Japanese standard methods. A mixture of mulberry leaves was harvested from the three races “Hayate-sakari,” “Ichinose,” and “Minamisakari” at a ratio of 5:3:2 in the Kyotango Furusato Farm. Mulberry leaf powder was prepared by drying and milling at 180 °C for 8 s in a hot-air mill (Drymeister, Hosokawa Micron, Osaka, Japan). The average diameter of the dried powder used in this experiment was 20 μm.
Animals and diets
Five-week-old (5-w) male db/db mice and regular chow were purchased from Oriental Bio Service (Kyoto, Kyoto, Japan). The db/db mice were randomly allocated into two diet-groups, control-diet group and ML-diet group. Each diet group was further divided into three groups (each n = 6) by feeding duration from 7-w age to 10, 15, or 20-w age. Mice of all diet groups were provided ad libitum access to regular chow diet and water and were acclimated for at least 7 days under conditions of controlled temperature and a 12 h light/dark cycle. From 7-w of age, mice of the control-diet group were fed regular chow diet consisting of 4.8% fat, 61.4% carbohydrate, 20.8% protein, 8.0% water and 5.0% ash, while the ML-diet group were fed regular chow containing 5% (w/w) dried ML. The diets were stored at 4 °C until use. Mice of each diet group were euthanized at 10, 15 and 20 weeks of age, bloods were collected, and pancreas tissues were removed and frozen in liquid nitrogen. All samples were stored at − 80 °C. All procedures were approved by the Kyoto University.
Blood analysis and glucose tolerance test
All blood samples were collected following an overnight fast. Blood glucose levels and insulin concentrations were measured using the commercial kits, Glucose CII test Wako kit (Mutarotase-GOD method, Wako Pure Chemical Industries, Osaka, Japan) and Morinaga Ultra-Sensitive Mouse/Rat Insulin ELISA kit (MIoBS, Yokohama, Japan), respectively. For the intraperitoneal glucose tolerance test (ipGTT), mice were subjected to fasting for 16 h, and intraperitoneally injected with 1.5 g/kg of D-glucose (Wako). Blood samples were collected before and then sequentially after injection. The ipGTT tests were done on the same day for mice from the same age group of both diet groups.
The pancreases were fixed overnight in 4% paraformaldehyde (Wako) and embedded in paraffin. Sections were incubated with primary antibodies overnight at 4 °C. DAPI (diamidino-2-phenylindole) dye (Invitrogen, Carlsbad, CA, USA) was used to detect nuclei in immunofluorescent images. Primary antibodies used were as follows: mouse anti-insulin + proinsulin antibody (Abcam, Cambridge, MA, USA, ab8304, 1:1250), rabbit anti-insulin (Santa Cruz Biotechnology, Dallas, TX, USA, sc-9168, 1: 1000), rabbit anti-CHOP (anti-GADD153) (Santa Cruz, sc-575, 1:1000), mouse anti-ATF4 (Proteintech, Rosemont, IL, USA, 10835–1-AP, 1:200), mouse anti-PCNA (Santa Cruz, sc-56, 1:1000), rabbit anti-PDX1 (Abcam, ab134150, 1:500). Alexa Fluor-conjugated chicken antibodies were used as secondary antibodies (Invitrogen).
Pancreases were fixed overnight with 4% paraformaldehyde and embedded in paraffin. In order to detect apoptotic cells, a TUNEL assay was performed using the ApopTag fluorescein in situ apoptosis detection kit (Millipore, Massachusetts USA). Sections were triple stained with a TUNEL kit, anti-insulin antibodies, and DAPI. After being stained, the sections were observed under a confocal fluorescence microscope (BZ8100, KEYENCE, Osaka, Japan), and the ratio of TUNEL-positive cells in insulin-positive cells was calculated.
RNA preparation and reverse transcription quantitative PCR (RT-qPCR)
Total RNA was extracted from the pancreases using a RNeasy mini kit (Qiagen, Valencia, CA, USA) and cDNA was prepared via a high-capacity cDNA Reverse Transcription kit (Applied Biosystems, Forster City, CA, USA). Samples were analyzed using the 7300 Real-Time PCR System (Applied Biosystems) using the Power SYBR Green PCR Master Mix (Applied Biosystems). The following primers were used: β-actin: Forward, 5′-CCTGAGCGCAAGTACTCTGTGT-3′; Reverse, 5′-GCTGATCCACATCTGCTGGAA-3′; Atf4: Forward, 5′- GGACAGATTGGATGTTGGAGAAAATG-3′; Reverse, 5′-GGAGATGGCCAATTGGTTCAC-3′; Bip: Forward, 5′-GTTTGCTGAGGAAGACAAAAAGCTC-3′; Reverse, 5′-CACTTCCATAGAGTTTGCTGATAAT-3′; Chop: Forward, 5′-GTCCAGCTGGGAGCTGGAAG-3′; Reverse, 5′-CTGACTGGAATCTGGAGAG-3′; Pdx1: Forward, 5′-ACTTGAGCGTTCCAATACGC-3′, Reverse, 5′-AGAGGGGGAACGACTCTAGG − 3′; proinsulin (pro-ins): Forward, 5′-TCTTCTACACACACCCATGTCCC-3′; Reverse, 5′-GGTGCAGCACTGATCCAC-3′; Xbp1: Forward, 5′-TGGGCATCTCAAACCTGCTT-3′; Reverse, 5′-GCGTCCAGCAGGCAAGA-3′. All experiments were performed in duplicate. Results were normalized to β-actin expression level, and relative mRNA levels of the ML-diet group compared to that of the control-diet group were calculated using the 2^(−ΔΔCt) method.
Data were presented as mean ± standard error of the mean (SEM). All data were analyzed using Kaleida Graph software (version 4.5; Synergy software, Reading, PA, USA). The trapezoidal rule was used to determine the net incremental area under the curve (net AUC). The ‘t’ test was used to determine statistically significant differences. Statistical significance was set at P < 0.05.
ML-diet maintained glucose-induced insulin secretion in db/db mice
To investigate the effects of a ML-diet on insulin level, db/db mice were fed with regular chow containing 5% (w/w) dried ML powder, from 7-weeks (7-w) of age to 20-w of age. The average body weight at 10, 15, and 20-w of age did not change between the ML-diet group and the control-diet group, suggesting that ML did not affect either the amount of food eaten or the growth of mice (Table 1). Next, immunohistological staining of pancreatic β-cells was performed using anti-insulin antibodies. The results showed that the insulin-positive area in pancreatic sections increased at 15-w compared to that at 10-w in both diet groups, while it decreased at 20-w of age (Fig. 1a). Compared to the control-diet group, pancreases of the ML-diet group showed significantly larger insulin-positive areas at 15-w and 20-w of age, suggesting that the increase in β-cell numbers was larger in the ML-diet group than that in the control-diet group. In addition, quantitative analyses indicated that mRNA expression levels of proinsulin (pro-ins) in the pancreas of mice from the ML-diet group at 15-w was significantly higher than that of the control group (Fig. 1b).
Next, intraperitoneal glucose tolerance tests (ipGTT) were performed for 10-w old and 15-w old db/db mice as shown Fig. 2. The results showed that the ML-diet group at 10-w of age exhibited significantly decreased glucose levels compared with those of the control-diet group (Figs. 2 a-1 and a-2), while there was no significant difference between the two diet groups at 15-w of age (Figs. 2 b-1 and b-2). Interestingly, plasma insulin levels of the 10-w old and 15-w old mice in the ML-diet group were not changed (Figs. 2, black in a-3 and b-3), while plasma insulin levels in the control group were dramatically decreased (Figs. 2, white in a-3 and b-3). These results demonstrated that ML-intake maintained β-cell function.
The effect of ML-diet on ER stress in the pancreas
ER stress in β-cells, accompanied by the secretion of mature insulin, is involved in the progress of T2DM. To reveal mechanisms underlying significantly large increases of β-cell mass in the ML-diet group, the effects of ML-diet suppression on cell death and ER stress in the pancreas were examined. TUNEL-positive β-cells in the pancreases of the ML-diet group were significantly reduced compared to those in the control-diet group, suggesting that ML intake suppressed apoptosis of β-cells (Fig. 3). Next, mRNA levels of various ER stress markers in the pancreases were quantified via RT-qPCR. The results showed that the mRNA level of Chop at 10-w of age and those of ER stress markers, Bip, Chop, Atf4, and Xbp1, at 15-w of age, were significantly reduced by the ML-diet compared to those of the control-diet (Fig. 4a). In addition, immunohistochemical analyses of islets demonstrated that expression of both CHOP and ATF4 proteins were also decreased in the ML-diet group than that in the control diet group (Fig. 4b). Considered together, these data suggested that ML-diet suppressed β-cell apoptosis by reducing ER stress, thereby maintaining β-cell function.
The effect of ML-diet on β-cell proliferation
β-cell proliferation was evaluated via immunohistological staining with anti-PCNA (proliferating cell nuclear antigen) antibodies. PCNA-positive cells were significantly increased (P < 0.01) in the pancreases of the ML-diet group compared to those in the control-diet group (Fig. 5a). Next, the expression of pancreatic duodenum homeobox-1 (Pdx1), a marker of pancreatic bud cells in the pancreas, in 15-w old mice, was examined using immunostaining and RT-qPCR. Results indicated that the expression of both protein and mRNA of Pdx1 in the ML-diet group was significantly increased compared to that in the control-diet group (Figs. 5b and c). These results suggested that the ML-diet may induce pancreatic β-cell proliferation.
Diabetes mellitus is a common metabolic disorder characterized by the destruction of pancreatic β-cells or diminished secretion and function of insulin . In order to elucidate mechanisms for the enhanced glucose tolerance effects of ML, the current study analyzed the effect of oral ML administration from 7 weeks onwards on pancreatic β-cells, using db/db mice. The insulin-positive area was increased at 15-w of age compared with that of 10-w in both diet groups, while it was decreased at 20-w of age (Fig. 1a). This age-dependent change in β-cell mass suggested that an increase in β-cell mass occurred at the compensation stage but decreased subsequently at the decompensation stage. Observation of the β-cell area of 15-w and 20-w old mice demonstrated that ML administration has the potential to maintain β-cells (Fig. 1a). The β-cell area in the pancreas of 15-w old ML-diet mice was larger than that of the control-diet group, suggesting that an ML diet may enhance the increase in β-cell mass at the compensation stage. This effect of an ML-diet may help to maintain β-cell mass at the decompensation stage. These effects on β-cells are supported by ipGTT results (Fig. 2).
To reveal the mechanism that maintains β-cell mass via an ML-diet, cell death and proliferation were analyzed. Results indicated that an ML-diet reduced apoptotic death of β-cells compared with that of the control group (Fig. 3) and suppressed the expression of genes encoding ER stress markers in the pancreas (Fig. 4). These finding suggested that cell death was suppressed by the reduction of ER stress due to ML-intake. Furthermore, an ML-diet enhanced proliferation of β-cells (Fig. 5). Thus, demonstrating that an ML-diet may maintain the β-cell mass via both enhancement of proliferation at the compensation stage and reduction of cell death at the decompensation stage in db/db mice.
Many studies have reported that the intake of some natural plant products improves insulin resistance and suppresses hyperglycemia, without affecting the expression of the BiP/GRP78 chaperone in response to ER stress. Kim et al., reported that a traditional Korean medicine known as Chinese mulberry (Cudrania tricuspidata), which is in the Moraceae family, suppressed expression of ER stress marker mRNAs, such as Chop and Atf4, in the liver of db/db mice, while no significant change was observed in the expression of Bip/grp78 . By contrast, the current study demonstrated that an ML-diet suppressed the expression of Bip, a chaperone, in the pancreas. Another study reported that ML supplementation suppressed the expression of bip/grp78 in the myocardia of experimental autoimmune myocarditis rats . These findings suggest that ML may possess a special capability for bioactivity among herbs that reduce ER stress.
Furthermore, other studies have indicated that quercetin suppressed the expression of bip/grp78 in the intestinal human colon adenocarcinoma cell line LS180 , and also suppressed the expression of bip/grp78 and Chop, induced via tunicamycin in endothelial cells . ML is known to contain quercetin 3-O-glucoside and kaempherol 3-O-glucoside [27, 28]. Furthermore, Enkhmaa et al. identified quercetin 3-(6-malonylglucoside) (Q3MG) as a main antioxidant contained in ML, and showed that Q3MG attenuated the development of atherosclerotic lesions is mouse models , as opposed to quercetin, which did not. Quercetin is minimally absorbed by the intestine, and therefore flavonoid glycoconjugates may be responsible for the maintenance of β-cell mass by ML intake. However, since these flavonoids are also contained in various other plants, further studies may be needed to clarify the specific bioactivity of ML.
Our experiments demonstrated that an ML-diet promoted β-cell proliferation and enhanced Pdx1 expression (Fig. 5). A previous study indicated that impaired activation of the insulin signaling pathway, P13K and protein kinase B (PKB/Akt) signaling, suppressed Pdx1 expression , leading to the dysfunction of mature β-cells . Other studies have demonstrated that regeneration of β-cells is mediated by Pdx1 expression. For example, spontaneous diabetes in a zebrafish model recovered rapidly following chemical treatment, due to PCNA-Pdx1 positive cells differentiating into β-cells . These reports indicate that upregulation of Pdx1 expression in db/db mice fed ML may induce β-cell regeneration.
Li et al. administered a mixture of polysaccharide and DNJ, a α-glucosidase inhibitor contained in ML, to mice in whom diabetes was induced via alloxan. They showed that insulin expression was upregulated via increased Pdx1 expression in the pancreas . Similarly, in an in vitro model, dysfunctional β-cells induced by fructose showed a significant increase in cell proliferation by incubation with quercetin, suggesting that quercetin may prevent β-cell dysfunction . In addition, substances such as charcoal were found in the flowering stages of ML. Hu et al. treated RIN-5F cells, rat pancreatic β-cells stimulated by high glucose, with charcoal extracted from dried flower buds (Cleistocalyx operculatus). The results showed that dried flower buds protected cells from damage by suppressing nitric oxide (NO) production and increasing the mRNA expression of pro-insulin and Pdx1 . These reports substantiate the results of the present study, confirming that ML-intake increased Pdx1 expression, which in turn promoted β-cell proliferation.
In conclusion, this study indicated that ML-intake maintains β-cell mass via both mechanisms, induction of β-cell proliferation and suppression of β-cell apoptosis, in mouse obesity/T2DM models. It was also shown that the suppression of β-cell apoptosis was caused by reduced ER stress. Moreover, ML-intake enhanced Pdx1 expression in the pancreas, thereby restoring β-cell function as proposed in Fig. 6. Considered together, these findings suggested that ML contains several bioactive substances which exhibit complementary potency and may be useful for developing an effective treatment regimen for diabetes mellitus.
Availability of data and materials
The datasets used and/or analyzed during the current study available from the corresponding author on a reasonable request.
Proliferating cell nuclear antigen
Reactive oxygen species
Terminal deoxynucleotidyl transferase mediated dUTP nick end labeling
Immunoglobulin heavy-chain binding protein
Glucose related protein 78
Inositol requiring enzyme 1
PKR like endoplasmic reticulum kinase
Activating transcription factor 6
- ATF4 :
Activating transcription factor 4
- XBP1 :
X-box binding protein1
- CHOP :
C/EBP homologous protein
- Pdx1 :
Pancreatic duodenal homeobox1
Reverse transcription quantitative polymerase chain reaction
Intraperitoneal glucose tolerance tests
Area under the curve
Lingohr MK, Buettner R, Rhodes CJ. Pancreatic β-cell growth and survival-a role in obesity-linked type 2 diabetes? Trends Mol Med. 2002;8:375–84.
World Health Organization. Global Report on Diabetes. World Health Organization, vol. 978; 2016. p. 88.
Rhodes CJ. Type 2 diabetes - a matter of β-cell life and death? Science. 2005;307:380–4.
Horvth B, Mukhopadhyay P, Hask G, Pacher P. The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am J Pathol. 2012;180:432–42.
Prentki M, Nolan C. Review series islet β cell failure in type 2 diabetes. J Clin Investig. 2006;116:1802–12.
Liu Q, Li X, Li C, Zheng Y, Wang F, Li H, Peng G. 1-Deoxynojirimycin alleviates liver injury and improves hepatic glucose metabolism in db/db mice. Molecules. 2016;21:1–12.
Hansawasdi C, Kawabata J. α-Glucosidase inhibitory effect of mulberry (Morus alba) leaves on Caco-2. Fitoterapia. 2006;77:568–73.
Weir GC, Laybutt DR, Kaneto H, Bonner-weir S, Sharma A. β cell adaptation and decompensation during the progression of diabetes. Diabetes. 2001;50:s154–9.
Weir GC, Bonner-Weir S. Five stages of evolving β cell dysfunction during progression to diabetes. Diabetes. 2004;53:s16–s210.
Shen X, Zhang K, Kaufman RJ. The unfolded protein response a stress signaling pathway of the endoplasmic reticulum. J Chem Neuroanat. 2004;28:79–92.
Cao SS, Kaufman RJ. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opinions on Therapeutic Targets. 2013;17:434–48.
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435:677–81.
Araki E, Oyadomari S, Mori M. Diabetes mellitus and endoplasmic reticulum stress. Intern Med. 2003;42:7–14.
Piperi C, Adamopoulos C, Papavassiliou AG. XBP1: a pivotal transcriptional regulator of glucose and lipid metabolism. Trends Endocrinol Metab. 2016;27:119–22.
Winnay JN, Dirice E, Liew CW, Kulkarni RN, Kahn C. p85α deficiency protects β cell from endoplasmic reticulum stress induced apoptosis. Proc Natl Acad Sci U S A. 2014;111:1192–7.
Kojima Y, Kimura T, Nakagawa K, Asai A, Hasumi K, Shinichi O, Teruo M. Effects of mulberry leaf extract rich in 1-Deoxynojirimycin on blood lipid profiles in humans. J Clin Biochem Nutr. 2014;47:155–61.
Harauma A, Murayama T, Ikeyama K, Sano H, Arai H, Ryo T, Toru K, Saburo H, Kaeko K, Masayuki Y. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2007;358:751–6.
Sugimoto M, Arai H, Tamura Y, Murayama T, Parinda K, Takuya N, Koh O, Hiroyuki A, Takashi A, Yukihiko U, Toru K, Shigeharu H, Kaeko K, Masayuki Y. Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db mice. Atherosclerosis. 2008;204:388–94.
Gryn-Rynko A, Bazylak G, Olszewska-Slonina D. New potential phytotherapeutics obtained from white mulberry (Morus alba L.) leaves. Biomed Pharmacother. 2016;84:628–36.
Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard JF, Gross R, Petit P, Bataille D, Oiry C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010;161:799–814.
Zhang R, Yao Y, Wang Y, Ren G. Antidiabetic activity of isoquercetin in diabetic KK–ay mice. Nutrition and Metabolism. 2011;8:1–6.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting : the ARRIVE guidelines for reporting animal research. PLoS One. 2010;8:6–10.
Kim O, Nam D, Jun W, Lee J. Cudrania tricuspidata water extract improved obesity-induced hepatic insulin resistance in db/db mice by suppressing ER stress and inflammation. Food Nutr Res. 2015;59:1–12.
Arumugam S, Thandavarayan RA, Veeraveedu PT, Ma M, Giridharan VV, Arozal W, Sari FR, Sukumaran V, Lakshmanan A, Soetikno V, Suzuki K, Kodama M, Watanabe K. Modulation of endoplasmic reticulum stress and cardiomyocyte apoptosis by mulberry leaf diet in experimental autoimmune myocarditis rats. J Clin Biochem Nutr. 2012;50:139–44.
Natsume Y, Ito S, Satsu H, Shimizu M. Protective effect of quercetin on ER stress caused by calcium dynamics dysregulation in intestinal epithelial cells. Toxicology. 2009;258:164–75.
Suganya N, Dornadula S, Chatterjee S, Mohanram RK. Quercetin improves endothelial function in diabetic rats through inhibition of endoplasmic reticulum stress-mediated oxidative stress. Eur J Pharmacol. 2017;819:80–8.
Katan MB. Bioavailabilities of Quercetin-3- Glucoside do not differ in human. J Nutr. 2002;2:1200–3.
Wei M, Mahady GB, Liu D, Zheng ZS, Lu Y. Astragalin, a flavonoid from Morus alba (mulberry) increases endogenous estrogen and progesterone by inhibiting ovarian granulosa cell apoptosis in an aged rat model of menopause. Molecules. 2016;21:1–15.
Enkhmaa B, Shiwaku K, Katsube T, Kitajima K, Anuurad E, Masayuki Y, Yosuke Y. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J Nutr. 2005;135:729–34.
McKinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia. 2001;44:1203–14.
Holland AM, Go LJ, Naselli G, Macdonald RJ, Harrison LC. Conditional expression demonstrates the role of the maintenance and regeneration of β-cells in the adult. Diabetes. 2005;54:2586–95.
Moss JB, Koustubhan P, Greenman M, Parsons MJ, Walter I, Larry GM. Regeneration of the pancreas in adult zebrafish. Diabetes. 2009;58:1844–51.
Li Y, Ji D, Zhong S, Zhi-Qiang L, Lin T, Shi C, Gui-Yan H. Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1 / insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice. J Ethnopharmacol. 2011;134:961–70.
Li JM, Wang W, Fan CY, Wang MX, Zhang X, Qing-Hua H, Ling-Dong K. Quercetin preserves β cell mass and function in fructose-induced Hyperinsulinemia through modulating pancreatic Akt/FoxO1 activation. Evid Based Complement Alternat Med. 2013:1–12.
Hu YC, Hao DM, Zhou LX, Zhang Z, Huang N, Michael H, Yan-Hua L. 2′,4′-Dihydroxy-6′-methoxy-3′,5′-dimethylchalcone protects the impaired insulin secretion induced by Glucotoxicity in pancreatic β-cells. J Agric Food Chem. 2014;62:1602–8.
We thank Ms. Erina Tajima and Ms. Yoshiko Fujiwara for their time and skilful technical assistance.
This work was supported in part by the grants from the Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research (KAKENHI) 26460338, 17 K08592 (to M. Minami), and 15 K08230 (to M. Yokode); the Metabolic Syndrome Research Forum Fund; the Takeda Science Foundation; and the SENSHIN Medical Research Foundation (to M. Minami). This work was also partially supported by Grants-in-Aid from JSPS Core-to-Core program, B. Asia-Africa Science Platforms (to K. Kamei) and by the grants from the Kobayashi Foundation (to K. Kamei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.
Ethics approval and consent to participate
All animals used in the study were handled in accordance with the guidelines approved by the animal ethics committee of Kyoto University (approval No. MedKyo 19301).
Consent for publication
The authors declare that they have no completing of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Suthamwong, P., Minami, M., Okada, T. et al. Administration of mulberry leaves maintains pancreatic β-cell mass in obese/type 2 diabetes mellitus mouse model. BMC Complement Med Ther 20, 136 (2020). https://doi.org/10.1186/s12906-020-02933-4
- Mulberry leaves
- Endoplasmic reticulum stress
- Type 2 diabetes